Why the study?
Are specific cardiovascular biomarkers differentially associated with incident HFrEF versus incident HFpEF?
Are specific cardiovascular biomarkers differentially associated with incident HFrEF versus incident HFpEF?
Different biomarker profiles predict incident HFrEF versus HFpEF, highlighting distinct pathophysiological pathways and a need for novel predictive biomarkers specifically for HFpEF.
No takes yet. Share an insight, caveat, or question.
Differential biomarker profiles suggest distinct HFrEF and HFpEF pathways; hypothesis-generating and requires prospective validation before clinical use.
Boer et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: